Oncologie nieuws
- Intermittent energy restriction inhibits tumor growth and enhances paclitaxel response in a transgenic mouse model of endometrial cancer
- Response to: The Synergism of Public Health Policies and Social Work May Reduce Mortality from Cancer, Liver Disease and Cardiovascular Disease
- Exploring Hepatocellular Carcinoma Risks in Sub-Saharan African and Afro-Surinamese Individuals with Chronic Hepatitis B living in Europe
- Causes and impact of delays during the COVID?19 pandemic on head and neck cancer diagnosis
- FDA Approves Nogapendekin Alfa Inbakicept-pmln for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
- Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial
- Biological Age is No Barrier for Adult Patients Undergoing CAR T for Non-Hodgkin's Lymphoma or Multiple Myeloma
- First mRNA skin-cancer vaccine starts UK trial
- ImmunityBio gets US FDA nod for its Anktiva to treat patient with BCG?unresponsive non?muscle invasive bladder cancer
- FDA Approves Alectinib as Adjuvant Treatment for ALK-positive Non-Small Cell Lung Cancer
- US FDA accepts GSK's sBLA for Jemperli plus chemotherapy to expand treatment to all adult patients with primary advanced or recurrent endometrial cancer
- Expression of Concern: Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
- Erratum: Pathologic Exploration of the Axillary Soft Tissue Microenvironment and Its Impact on Axillary Management and Breast Cancer Outcomes
- Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy
- Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway